scholarly journals Craniofacial Morphology in Children with Growth Hormone Deficiency and Turner Syndrome

Diagnostics ◽  
2020 ◽  
Vol 10 (2) ◽  
pp. 88
Author(s):  
Dorota Wójcik ◽  
Iwona Beń-Skowronek

The review aims to collect and demonstrate recent knowledge about craniofacial morphology in growth hormone (GH)-deficient children and children with Turner syndrome. The review describes also the effects of growth hormone treatment on craniofacial morphology of children with growth hormone deficiency and Turner syndrome. Regardless of the disorder it accompanies, short stature is associated with similar craniofacial features characteristic of all short-statured children. Characteristic craniofacial features involve lesser dimensions of the cranial base and mandibular length, proportionately smaller posterior than anterior facial height, retrognathic face, and posterior rotation of the mandible. We also analyze orthodontic treatment in children affected by disorders associated with GH deficiency or provided with growth hormone treatment in the aspect of craniofacial growth. Recent publications show also the connection between growth hormone receptor polymorphism and craniofacial growth. Specialists and orthodontists treating short-statured children must be aware of the results of studies on craniofacial morphology and educate themselves on the topic of craniofacial growth in children with short stature. Moreover, knowledge of the influence of GH therapy on growth of craniofacial structures is necessary to decide the proper timing and planning of orthodontic treatment.

Author(s):  
A. J. Weissberger ◽  
R. C. Cuneo ◽  
F. Salomon ◽  
G. A. McGauley ◽  
C. Lowy ◽  
...  

2020 ◽  
Author(s):  
Selina Graham ◽  
Samantha Neo ◽  
Vivian Auyeung ◽  
John Weinman

Objective: A recent systematic review reported that up to 71% of patients with growth hormone deficiency and their families are non-adherent to treatment as prescribed. Non-adherence to growth hormone treatment presents a substantial and costly problem for the patient, healthcare provider and healthcare system. The current study uniquely investigates the potentially modifiable factors associated with treatment non-adherence in this endocrine disorder. Methods: The cross-sectional study was conducted among 82 parent/caregivers of children with growth hormone deficiency and receiving growth hormone treatment. Self-report questionnaires investigated parents/caregivers’ perceptions and experiences of their child’s condition and prescribed treatment, in addition to their perceived relationship with their healthcare professional. The eight-item Morisky Medication Adherence Scale was used for the assessment of treatment adherence. Results: 62% of parent/caregivers were found to be non-adherent to growth hormone treatment as prescribed. Illness perceptions [consequences, identity and coherence] and treatment concerns were found to be significantly associated with treatment adherence, as was the quality of the healthcare professional-parent/caregiver relationship. Conclusion: The study confirms the extent of the adherence problem evident amongst the paediatric growth hormone deficiency population. In addition, it presents an insight into the explanatory factors that underpin non-adherence to growth hormone treatment. Our findings can be used to inform the development of adherence-focussed interventions, with the purpose to support patients and their families and improve the use of prescribed growth hormone treatment within endocrine clinical practice. Abbreviations: GHD = Growth Hormone Deficiency; rhGH = Recombinant Human Growth Hormone treatment; HCP = Healthcare Professional; MMAS = Morisky Medication Adherence Scale; BIPQ = Brief Illness Perception Questionnaire; BMQ = Beliefs about Medicines Questionnaires-Specific; PHR = Parent-Healthcare Provider Relationship-AIRS© Section II; COM-B = Capability, Opportunity, Motivation – Behavior.


Sign in / Sign up

Export Citation Format

Share Document